NEWS

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

[August 20, 2020]

CAMARILLO, Calif., Aug. 18, 2020 /PRNewswire/ -- ImmPACT Bio USA Inc., a company founded in the FutuRx incubator located in Ness Ziona, Israel, developing novel cell therapies for treating cancer, today announced the closing of a US$ 18 million equity financing round. The financing included OrbiMed, Johnson & Johnson Innovation – JJDC, Inc., Takeda Ventures, Inc., RM Global Partners (RMGP) BioPharma Investment Fund, Novartis Venture Fund, Bukwang Pharmaceutical, Hayan Health Networks, Inc., and JVC Investment Partners. ImmPACT Bio USA...

R&D

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

[August 20, 2020]

CAMARILLO, Calif., Aug. 18, 2020 /PRNewswire/ -- ImmPACT Bio USA Inc., a company founded in the FutuRx incubator located in Ness Ziona, Israel, ...

PRODUCTS
COMPANY

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a health...

|    ​Korean    |

7, Sangdo-ro, Dongjak-gu, Seoul, Korea 06955   Tel : 02)8288-114   Fax : 02)8288-029   CS : 02)8288-114

Copyright © 2015 Bukwang Pharmaceutical Co., Ltd.All Rights Reserved.

  • Facebook Basic Square
  • Google+ Basic Square